LuCAB: A phase I/II trial evaluating cabazitaxel in combination with [ 177 Lu]Lu-PSMA-617 in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).
- Resource Type
- Article
- Source
- Journal of Clinical Oncology; 2/21/2023 Supplement, Vol. 41, pTPS278-TPS278, 1p
- Subject
- Language
- ISSN
- 0732183X